Life Sciences
USA Guide 2024 : USA - Nationwide
Band 3
Email address
[email protected]Contact number
+1 650 988 8500Chambers Review
Fenwick has a respected practice noted for its ability to represent life sciences companies of all sizes on a broad range of matters. The firm regularly represents clients in complex IP disputes including Hatch-Waxman litigation and trademark infringement matters. It offers additional capabilities advising on transactional mandates including public offerings and M&A, as well as patent prosecution and portfolio management.
Melanie Mayer, Matthew Rossiter and Stefano Quintini colead the department and are key contacts.
Work Highlights
- Fenwick continued to represent Novo Nordisk in Hatch-Waxman patent litigation arising from ANDAs filed with the FDA by six generics, seeking approval to market generic versions of Novo Nordisk's GLP-1 diabetes treatment, Ozempic.
Strengths
Provided by Chambers
"The Fenwick team is superb."
"I am particularly impressed by the Fenwick's team approach and ability to efficiently pull in additional resources."
"The Fenwick team is superb."
"I am particularly impressed by the Fenwick's team approach and ability to efficiently pull in additional resources."